1999
Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: A randomized, vehicle-controlled clinical trial
Heier J, Cheetham J, DeGryse R, Dirks M, Caldwell D, Silverstone D, Rosenthal A. Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: A randomized, vehicle-controlled clinical trial. American Journal Of Ophthalmology 1999, 127: 253-259. PMID: 10088733, DOI: 10.1016/s0002-9394(98)00413-9.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAged, 80 and overAnterior ChamberAnti-Inflammatory Agents, Non-SteroidalDouble-Blind MethodFemaleHumansKetorolac TromethamineLens Implantation, IntraocularMaleMiddle AgedOphthalmic SolutionsPain, PostoperativePhacoemulsificationSafetyTolmetinTreatment OutcomeTromethamineUveitis, AnteriorConceptsSevere anterior segment inflammationAnterior segment inflammationIntraocular lens implantationCataract surgeryVehicle solutionOphthalmic solutionLens implantationSubstantial anti-inflammatory activityVehicle-controlled clinical trialSafety of ketorolacAnterior chamber cellsParallel-group studyEye four timesUnilateral cataract surgerySevere ocular inflammationLack of efficacyAnti-inflammatory activityCiliary flushKetorolac groupTopical ketorolacAdverse eventsOcular inflammationOnly patientsVisual acuityIntraocular pressure
1992
Prophylactic Use of Apraclonidine for Intraocular Pressure Increase After Nd:YAG Capsulotomies
Silverstone D, Brint S, Olander K, Taylor R, McCarty G, deFaller J, Burk L. Prophylactic Use of Apraclonidine for Intraocular Pressure Increase After Nd:YAG Capsulotomies. American Journal Of Ophthalmology 1992, 113: 401-405. PMID: 1348396, DOI: 10.1016/s0002-9394(14)76162-8.Peer-Reviewed Original ResearchConceptsVehicle-treated groupIntraocular pressurePosterior capsulotomyYAG laser posterior capsulotomyIncidence of increaseMean maximal changeMasked clinical trialIntraocular pressure increaseLaser posterior capsulotomyYAG posterior capsulotomyTreatment armamentariumProphylactic effectYAG capsulotomyProphylactic useAdverse reactionsClinical trialsVisual functionRelative safetyCapsulotomyMaximal changeApraclonidineGroupMulticenterPatientsArmamentarium